论文信息 - Tezepelumab improves patient-reported outcomes in patients with severe, uncontrolled asthma in PATHWAY. - 字舞流文

Tezepelumab improves patient-reported outcomes in patients with severe, uncontrolled asthma in PATHWAY.

K. Salapa | J. Corren | J. Parnes | E. Garcia Gil | J. Griffiths | R. van der Merwe | S. O'Quinn